All lobbying filings
Continental Strategy, LLC
Continental Strategy, LLC filed a Q1 report for Immix Biopharma, Inc. on April 20, 2026, reporting no lobbying activity.
Lobbying for Immix Biopharma, Inc. · A clinical-stage biopharmaceutical company.
Filing · LD-2 quarterly report
Q1 reportNo activity
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 20, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
California
Lobbying activity
0
No itemized activity in this filing.